NI
Nextech Invest Portfolio holdings
AUM
$528M
This Quarter Return
-1.32%
1 Year Return
-0.88%
3 Year Return
+164%
5 Year Return
–
10 Year Return
–
AUM
$594M
AUM Growth
+$594M
(-5.8%)
Cap. Flow
+$26.3M
Cap. Flow
% of AUM
4.42%
Top 10 Holdings %
Top 10 Hldgs %
93.96%
Holding
13
New
1
Increased
1
Reduced
–
Closed
–
Top Buys
| 1 |
Context Therapeutics
CNTX
|
$14.9M |
| 2 |
Mersana Therapeutics
MRSN
|
$11.4M |
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Revolution Medicines
RVMD
$7.1B
| $244M | 41.11% | 6,296,740 | – | – |
|
2
Tyra Biosciences
TYRA
$675M
| $64.9M | 10.91% | 4,055,861 | – | – |
|
3
Tango Therapeutics
TNGX
$747M
| $47.5M | 7.99% | 5,533,980 | – | – |
|
|
CRGX
4
DELISTED
CARGO Therapeutics
CRGX
| $43.4M | 7.3% | 2,642,502 | – | – |
|
5
Arvinas
ARVN
$568M
| $37.5M | 6.31% | 1,408,394 | – | – |
|
6
Oric Pharmaceuticals
ORIC
$994M
| $37.4M | 6.29% | 5,285,714 | – | – |
|
7
Relay Therapeutics
RLAY
$619M
| $25.1M | 4.22% | 3,846,409 | – | – |
|
8
Cullinan Oncology
CGEM
$445M
| $21.3M | 3.58% | 1,221,145 | – | – |
|
|
9
Mersana Therapeutics
MRSN
$36.5M
| $19.1M | 3.22% | 9,526,146 +5,669,825 | +147% | +$11.4M |
|
|
SLN
10
Silence Therapeutics
SLN
$227M
| $18.1M | 3.04% | 952,400 | – | – |
|
11
ARS Pharmaceuticals
SPRY
$1.15B
| $16.3M | 2.73% | 1,910,029 | – | – |
|
|
12
Context Therapeutics
CNTX
$75.4M
| $14.9M | 2.5% | +7,419,355 | New | +$14.9M |
|
|
BOLD
13
Boundless Bio
BOLD
$25.1M
| $4.75M | 0.8% | 1,228,069 | – | – |
|